What does meaningful innovation look like in oncology?
Dr. Chad Levitt believes it’s not just about new technology, it’s about how we use it. In this video, he shares a clinician’s perspective on what makes AI valuable at the point of care: relevance, clarity, and trust.
With clinical teams already overwhelmed by fragmented, constantly evolving oncology data, what they don’t need is more information. What they do need is the right information. And they need it delivered in a way that fits their clinical workflows and supports real-time treatment decisions.
That’s the vision behind Oncoscope-AI, a hybrid platform that combines the speed of artificial intelligence with the insight of expert human review. It’s designed specifically for oncology teams, not just to summarize data, but to organize, interpret, and prioritize it with clinical nuance.
Dr. Levitt’s message is clear, Tools like Oncoscope aren’t here to replace clinicians. They’re here to support them in doing what they do best, making confident, evidence-based decisions for their patients.
“We don’t need more noise. We need intelligent filtering. That’s what makes AI useful in practice, not just possible in theory.” – Dr. Chad Levitt
Beka Vinogradov is the Digital Communications Lead for Oncoscope-AI. She holds a Master’s in Health Administration and has extensive experience and education in business, marketing, and design.
